P252 Results of a phase 2/3 study of SCIG 20% in PIDD patients in North America
Autor: | Suez, D., Melamed, I., Hussain, I., Stein, M., Gupta, S., Paris, K., Bourgeois, C., Leibl, H., McCoy, B., Yel, L. |
---|---|
Zdroj: | In Annals of Allergy, Asthma & Immunology November 2016 117(5) Supplement:S97-S97 |
Databáze: | ScienceDirect |
Externí odkaz: |